WHO ICTRP trial

Neuromodulation for reducing neurogenic detrusor overactivity in spinal cord…

ISRCTN99373118 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN99373118
Public title Neuromodulation for reducing neurogenic detrusor overactivity in spinal cord injury
Scientific title Investigating transcutaneous neuromodulation for reduction of bladder, bowel and spasticity in spinal cord injury as an alternative to pharmacological treatment: towards wearable devices
Primary sponsor Royal National Orthopaedic Hospital NHS Trust
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries United Kingdom
Conditions Specialty: Renal disorders, Primary sub-specialty: Renal disorders Urological and Genital Diseases Renal disorders
Interventions To ascertain the most effective transcutaneous stimulation site the efficacy of neuromodulation using surface electrodes is investigated at distinct anatomical sites: Dorsal Genital Nerve, Posterior Tibial Nerve, Sacral Roots and Spinal…
Registration date Jul 7, 2017
Target size 20
Secondary IDs 20733
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations